Takamatsu Yuki

Takamatsu Yuki

National Center for Global Health and Medicine - Tokyo / Japan
Others
AD Scientific Index ID: 4606311
国立国際医療研究センター
person_outline Takamatsu Yuki's MOST POPULAR ARTICLES
1-) A small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replicationS Hattori, N Higashi-Kuwata, H Hayashi, SR Allu, J Raghavaiah, H Bulut, ...Nature communications 12 (1), 1-12, 2021882021
2-) Correlates of neutralizing/SARS-CoV-2-S1-binding antibody response with adverse effects and immune kinetics in BNT162b2-vaccinated individualsK Maeda, M Amano, Y Uemura, K Tsuchiya, T Matsushima, K Noda, ...Scientific reports 11 (1), 1-10, 2021482021
3-) GRL-0920, an indole chloropyridinyl ester, completely blocks SARS-CoV-2 infectionS Hattori, N Higshi-Kuwata, J Raghavaiah, D Das, H Bulut, DA Davis, ...MBio 11 (4), 10.1128/mbio. 01833-20, 2020542020
4-) 4′‐modified nucleoside analogs: Potent inhibitors active against entecavir‐resistant hepatitis B virusY Takamatsu, Y Tanaka, S Kohgo, S Murakami, K Singh, D Das, ...Hepatology 62 (4), 1024-1036, 2015562015
5-) Mechanism of darunavir (DRV)’s high genetic barrier to HIV-1 resistance: a key V32I substitution in protease rarely occurs, but once it occurs, it predisposes HIV-1 to develop …M Aoki, D Das, H Hayashi, H Aoki-Ogata, Y Takamatsu, AK Ghosh, ...MBio 9 (2), 10.1128/mbio. 02425-17, 2018532018